abstract |
Determining the hormonal effects of substances (I) by contacting Ewing sarcoma protein (EWP), or its derivatives, with nuclear receptors (NR), or their derivatives, and a test compound (X) and detecting the effect of (X) either on binding of EWP and NR or on the ligand-induced activity of NR. Independent claims are also included for the following: (1) use of EWP, or nucleic acid (II) encoding it, for identification and characterization of substances that modify activity of NR; and (2) determining disorders in the co-modulation mechanism between androgen receptors (AR) and EWP by measuring the cellular and/or tissue concentration of AR and EWP. |